ENDRA Life Sciences Q3 EPS $(1.02) Misses $(0.84) Estimate
Benzinga Newsdesk 4 days ago
NewsEarningsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(1.02) per share which missed the analyst consensus estimate of $(0.84) by 21.43 percent. This is a 51.43 percent increase over losses of $(2.10) per share
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(1.02) per share which missed the analyst consensus estimate of $(0.84) by 21.43 percent. This is a 51.43 percent increase over losses of $(2.10) per share from the same period last year.
